Brainstorm Cell Therapeutics, Inc.

NASDAQ:BCLI   3:59:54 PM EDT
3.72
-0.08 (-2.10%)
4:00:39 PM EDT: $3.84 +0.12 (+3.23%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Brainstorm Cell Therapeutics, Inc. Stock, NASDAQ:BCLI

1325 Avenue of Americas, 28th floor, New York, New York 10019
United States of America
Phone: +1.201.488.0460
Number of Employees: 40

Description

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NJ.